Exploring Alternative Treatment Choices for Multidrug-Resistant Clinical Strains of <i>Helicobacter pylori</i> in Mongolia

Exploring Alternative Treatment Choices for Multidrug-Resistant Clinical Strains of <i>Helicobacter pylori</i> in Mongolia

<i>Helicobacter pylori</i> is a pathogen related to severe diseases such as gastric cancer; because of rising antimicrobial-resistant strains, failure to eradicate <i>H. pylori</i> with antibiotics has increased worldwide. Multidrug-resistant <i>H. pylori</i> and...

Full description

Bibliographic Details
Main Authors:	Ayush Khangai, Batsaikhan Saruuljavkhlan, Dashdorj Azzaya, Boldbaatar Gantuya, Khasag Oyuntsetseg, Junko Akada, Takashi Matsumoto, Yoshio Yamaoka
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Series:	Microorganisms
Subjects:	<i>Helicobacter pylori</i> antibiotic resistance ciprofloxacin moxifloxacin rifabutin furazolidone
Online Access:	https://www.mdpi.com/2076-2607/11/12/2852

Similar Items

Utilization of an Automated Latex Agglutination Turbidity Assay for Assessing Gastric Mucosal Alteration during Helicobacter pylori Infection
by: Ayush Khangai, et al.
Published: (2024-01-01)

High Antibiotic Resistance of <i>Helicobacter pylori</i> and Its Associated Novel Gene Mutations among the Mongolian Population
by: Dashdorj Azzaya, et al.
Published: (2020-07-01)

Comparison of Ciprofloxacin-Based Triple Therapy with Conventional Triple Regimen for Helicobacter pylori Eradication in Children
by: Fatemeh Farahmand, et al.
Published: (2016-06-01)

Comparison of eradication rates of moxifloxacin–rifabutin triple therapy and bismuth quadruple therapy as second‐line regimens in patients with peptic ulcers
by: Chang Min Lee, et al.
Published: (2022-09-01)

Short-duration furazolidone therapy in combination with amoxicillin, bismuth subcitrate, and omeprazole for eradication of <i>Helicobacter pylori</i>
by: Hasan Salman, et al.
Published: (2010-01-01)

The prevalence of Helicobacter pylori infection and other risk factors among Mongolian dyspeptic patients who have a high incidence and mortality rate of gastric cancer
by: Oyuntsetseg Khasag, et al.
Published: (2018-04-01)

Rescue Therapy with Furazolidone in Patients with at Least Five Eradication Treatment Failures and Multi-Resistant <i>H. pylori</i> infection
by: Elena Resina, et al.
Published: (2021-08-01)

Rifabutin for the Treatment of <i>Helicobacter pylori</i> Infection: A Review
by: Javier P. Gisbert
Published: (2020-12-01)

Сlinical and molecular aspects of helicobacter pylori resistance to antimicrobial drugs
by: Y. A. Kucheryaviy, et al.
Published: (2013-12-01)

Optimization Strategies Aimed to Increase the Efficacy of <i>Helicobacter pylori</i> Eradication Therapies with Quinolones
by: Javier P. Gisbert
Published: (2020-11-01)

Rifabutin-Containing Triple Therapy (RHB-105) for Eradication of <i>Helicobacter pylori</i>: Randomized ERADICATE Hp Trial
by: Ira N. Kalfus, et al.
Published: (2020-10-01)

Mutations Related to Antibiotics Resistance in <i>Helicobacter pylori</i> Clinical Isolates from Bangladesh
by: Kartika Afrida Fauzia, et al.
Published: (2023-01-01)

Intermediate dose and course Furazolidone and Amoxicillin versus Metronidazole and Amoxicillin in quadruple therapy for eradication of Helicobacter Pylori
by: M Kashi Fard, et al.
Published: (2006-04-01)

Experience of using different schemes of eradication therapy for Helicobacter pylori infection and their effectiveness in Ukraine
by: V.V. Chernyavskyi, et al.
Published: (2024-03-01)

Initial Trials With Susceptibility-Based and Empiric Anti-H. pylori Therapies in Mongolia
by: Tsogt-Ochir Byambajav, et al.
Published: (2019-04-01)

Rifabutin-based Fourth and Fifth-line Rescue Therapy in Patients with for Helicobacter pylori Eradication Failure
by: Jihee Sung, et al.
Published: (2017-02-01)

Effectiveness of empirical <i>Helicobacter pylori</i> eradication therapy with furazolidone in Russia: results from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)
by: Dmitry S. Bordin, et al.
Published: (2023-03-01)

Furazolidone-based therapies for Helicobacter pylori infection: A pooled-data analysis
by: Angelo Zullo, et al.
Published: (2012-01-01)

Treatment with compound Lactobacillus acidophilus followed by a tetracycline- and furazolidone-containing quadruple regimen as a rescue therapy for Helicobacter pylori infection
by: Airu Liu, et al.
Published: (2020-01-01)

The Efficacy of Moxifloxacin-containing Triple Therapy after Hybrid Therapy Failure in Helicobacter pylori Eradication
by: Soohoon Kwon, et al.
Published: (2017-08-01)

Global Antimicrobial Resistance Gene Study of <i>Helicobacter pylori</i>: Comparison of Detection Tools, ARG and Efflux Pump Gene Analysis, Worldwide Epidemiological Distribution, and Information Related to the Antimicrobial-Resistant Phenotype
by: Ricky Indra Alfaray, et al.
Published: (2023-06-01)

Efficacy of Rabeprazole Combined with Amoxicillin or Furazolidone Dual Therapy in Eradicating Helicobacter pylori Infection
by: Qiaoqiao SHAO, Jing MA, Xuechun YU, Miao YU, Yabin QI, Ruobing HU, Peiru WEI, Wei XIAO, Bailing JIA, Songze DING
Published: (2022-10-01)

Pepsinogen and Serum IgG Detection Is a Valuable Diagnostic Method for <i>Helicobacter pylori</i> Infection in a Low-Prevalence Country: A Report from Sri Lanka
by: Dalla Doohan, et al.
Published: (2021-07-01)

Molecular characterization of rifabutin-resistance in refractory Helicobacter pylori infection in Taiwan
by: Chia-Jung Kuo, et al.
Published: (2024-01-01)

Rifabutin Use in <i>Staphylococcus</i> Biofilm Infections: A Case Series
by: James B. Doub, et al.
Published: (2020-06-01)

Аrginase/NO-synthase system сharacteristics in blood lymphocytes under effect of fluoroquinolones
by: І. V. Кovalenko, et al.
Published: (2019-05-01)

Influence of Type and Neutralisation Capacity of Antacids on Dissolution Rate of Ciprofloxacin and Moxifloxacin from Tablets
by: Alija Uzunović, et al.
Published: (2009-02-01)

Fluoroquinolones’ Biological Activities against Laboratory Microbes and Cancer Cell Lines
by: Ghadeer A. R. Y. Suaifan, et al.
Published: (2022-03-01)

Maintaining Fluoroquinolone Class Efficacy: Review of Influencing Factors
by: W. Michael Scheld
Published: (2003-01-01)

Beyond Low Prevalence: Exploring Antibiotic Resistance and Virulence Profiles in Sri Lankan Helicobacter pylori with Comparative Genomics
by: Kartika Afrida Fauzia, et al.
Published: (2025-02-01)

<i>Helicobacter pylori</i> Virulence Factors Exploiting Gastric Colonization and its Pathogenicity
by: Shamshul Ansari, et al.
Published: (2019-11-01)

Liposomal Drug Delivery against <i>Helicobacter pylori</i> Using Furazolidone and N-Acetyl Cysteine in Augmented Therapy
by: Muhammad Irfan Alam, et al.
Published: (2024-08-01)

Optical tuning of polymer functionalized zinc oxide quantum dots as a selective probe for the detection of antibiotics
by: Awadhesh Kumar Verma, et al.
Published: (2025-01-01)

Comparative effect of ciprofloxacin and moxifloxacin on the modulation of bile acid profiles and gut microbiota in rats
by: Meng-Meng Wang, et al.
Published: (2022-08-01)

Penetration of 0.3% ciprofloxacin, 0.3% ofloxacin, and 0.5% moxifloxacin into the cornea and aqueous humor of enucleated human eyes
by: G.C.M. Silva, et al.

Insulinotropic Potential of <i>Moxifloxacin</i> and <i>Gemifloxacin:</i> An In Vivo Rabbits Model Study Followed by Randomized Phase I Clinical Trial
by: Abid Ullah, et al.
Published: (2022-01-01)

Rifabutin Suppresses Inducible Clarithromycin Resistance in <i>Mycobacterium abscessus</i> by Blocking Induction of <i>whiB7</i> and <i>erm41</i>
by: Dinah Binte Aziz, et al.
Published: (2020-02-01)

Newer Therapies for Refractory <i>Helicobacter pylori</i> Infection in Adults: A Systematic Review
by: Ligang Liu, et al.
Published: (2024-10-01)

Levofloxacin-containing triple therapy versus bismuth-based quadruple therapy as regimens for second line anti- Helicobacter pylori
by: Mohammadreza Seyyedmajidi, et al.
Published: (2019-03-01)

Biofilm Formation and Antibiotic Resistance Phenotype of <i>Helicobacter pylori</i> Clinical Isolates
by: Kartika Afrida Fauzia, et al.
Published: (2020-07-01)